Last Price
0.04
Today's Change
-0.04 (50.00%)
Day's Change
0.035 - 0.06
Trading Volume
4,760,587
Exchange: Toronto Stock Exchange Toronto Stock Exchange
Currency: CAD CAD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Chris Savile Dr. Chris Savile
Full Time Employees: 19 19
IPO Date: 2021-02-11 2021-02-11
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.